Business News Samsung Biologics unveils $897 mln manufacturing deals for Pfizer South Korea’s Samsung Biologics (207940.KS) announced on Tuesday two deals with Pfizer (PFE.N) worth a combined $897 More… Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window) Related Airbus trials new wing designs in technology race with Boeing UAE President and UK Prime Minister discuss bilateral relations